Detalhe da pesquisa
1.
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Immunity;
56(11): 2570-2583.e6, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37909039
2.
TGF-ß-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures.
Immunity;
55(1): 115-128.e9, 2022 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35021053
3.
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.
Gynecol Oncol;
173: 114-121, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37121178
4.
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms.
Blood;
135(3): 191-207, 2020 01 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31750881
5.
Plasma of Acute Lymphoblastic Leukemia Patients React to the Culture of a Mycovirus Containing Aspergillus flavus.
J Pediatr Hematol Oncol;
42(5): 350-358, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32576782
6.
Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.
Blood;
120(5): 1027-38, 2012 Aug 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22692508
7.
A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies.
bioRxiv;
2023 Jul 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37461447
8.
Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Blood Adv;
7(18): 5586-5602, 2023 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37531660
9.
Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma.
Front Oncol;
12: 1044587, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36531031
10.
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.
Mol Cancer Ther;
21(7): 1184-1194, 2022 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35499393
11.
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer.
Cancer Res;
82(5): 859-871, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34949671
12.
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.
Cancer Cell;
40(5): 545-557.e13, 2022 05 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35427494
13.
Exposure to a mycovirus containing Aspergillus Flavus reproduces acute lymphoblastic leukemia cell surface and genetic markers in cells from patients in remission and not controls.
Cancer Treat Res Commun;
26: 100279, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33348275
14.
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
JCI Insight;
6(24)2021 12 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34793338
15.
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Clin Cancer Res;
15(10): 3406-15, 2009 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19401350
16.
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eµ-TCL1 Model.
Front Immunol;
11: 590072, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33329575
17.
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
Blood Adv;
4(13): 3072-3084, 2020 07 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32634240
18.
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
Blood Adv;
2(21): 3012-3024, 2018 11 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30425065
19.
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology.
J Leukoc Biol;
102(2): 475-486, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28550123
20.
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.
Mol Immunol;
63(2): 579-85, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25155994